Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes

被引:23
|
作者
Lenze, Nicholas R. [1 ]
Farquhar, Douglas [1 ]
Sheth, Siddharth [2 ]
Zevallos, Jose P. [3 ]
Blumberg, Jeffrey [1 ]
Lumley, Catherine [1 ]
Patel, Samip [1 ]
Hackman, Trevor [1 ]
Weissler, Mark C. [1 ]
Yarbrough, Wendell G. [1 ,5 ]
Zanation, Adam M. [1 ]
Olshan, Andrew F. [4 ]
机构
[1] Univ N Carolina, Sch Med, Dept Otolaryngol Head & Neck Surg, 170 Manning Dr,Campus Box 7070, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27515 USA
[3] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA
[4] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[5] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27515 USA
来源
LARYNGOSCOPE | 2021年 / 131卷 / 06期
关键词
Head and neck neoplasms; race; disparities; access to care; socioeconomic status; survival; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; AFRICAN-AMERICAN; HEALTH LITERACY; UNITED-STATES; ORAL-HEALTH; SURVIVAL; IMPACT; RACE;
D O I
10.1002/lary.29252
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis To determine drivers of the racial disparity in stage at diagnosis and overall survival (OS) between black and white patients with HPV-negative head and neck squamous cell carcinoma (HNSCC). Study Design Retrospective cohort study. Methods Data were examined from of a population-based HNSCC study in North Carolina. Multivariable logistic regression and Cox proportional hazards models were used to assess racial disparities in stage at diagnosis and OS with sequential adjustment sets. Results A total of 340 black patients and 864 white patients diagnosed with HPV-negative HNSCC were included. In the unadjusted model, black patients had increased odds of advanced T stage at diagnosis (OR 2.0; 95% CI [1.5-2.5]) and worse OS (HR 1.3, 95% CI 1.1-1.6) compared to white patients. After adjusting for age, sex, tumor site, tobacco use, and alcohol use, the racial disparity persisted for advanced T-stage at diagnosis (OR 1.7; 95% CI [1.3-2.3]) and showed a non-significant trend for worse OS (HR 1.1, 95% CI 0.9-1.3). After adding SES to the adjustment set, the association between race and stage at diagnosis was lost (OR: 1.0; 95% CI [0.8-1.5]). Further, black patients had slightly favorable OS compared to white patients (HR 0.8, 95% CI [0.6-1.0]; P = .024). Conclusions SES has an important contribution to the racial disparity in stage at diagnosis and OS for HPV-negative HNSCC. Low SES can serve as a target for interventions aimed at mitigating the racial disparities in head and neck cancer. Level of Evidence 4 Laryngoscope, 2020
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 50 条
  • [1] Community socioeconomic status and rural/racial disparities in HPV-/+ head and neck cancer
    Semprini, Jason
    Williams, Jessica C.
    TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY, 2023, 26
  • [2] Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes
    Waas, Matthew
    Karamboulas, Christina
    Wu, Benson Z.
    Khan, Shahbaz
    Poon, Stephanie
    Meens, Jalna
    Govindarajan, Meinusha
    Khoo, Amanda
    Mejia-Guerrero, Salvador
    Ha, Annie
    Liu, Lydia Y.
    Nixon, Kevin C. J.
    Walton, Joseph
    Bratman, Scott V.
    Huang, Shao Hui
    Goldstein, David
    Gaiti, Federico
    Ailles, Laurie
    Kislinger, Thomas
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma
    Lenze, Nicholas R.
    Farquhar, Douglas R.
    Sheth, Siddharth
    Zevallos, Jose P.
    Lumley, Catherine
    Blumberg, Jeffrey
    Patel, Samip
    Hackman, Trevor
    Weissler, Mark C.
    Yarbrough, Wendell G.
    Olshan, Andrew F.
    Zanation, Adam M.
    ORAL ONCOLOGY, 2021, 119
  • [4] Differential immune responses to HPV-positive and HPV-negative head and neck cancer
    Qureshi, Hannan A.
    Zhu, Xiaodong
    Lee, Sylvia M.
    Mendez, Eduardo
    Houghton, A. McGarry
    CANCER RESEARCH, 2019, 79 (13)
  • [5] FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner
    Pifer, Phillip M.
    Yang, Liangpeng
    Kumar, Manish
    Xie, Tongxin
    Frederick, Mitchell
    Hefner, Andrew
    Beadle, Beth
    Molkentine, David
    Molkentine, Jessica
    Dhawan, Annika
    Abdelhakiem, Mohamed
    Osman, Abdullah A.
    Leibowitz, Brian J.
    Myers, Jeffrey N.
    Pickering, Curtis R.
    Sandulache, Vlad C.
    Heymach, John
    Skinner, Heath D.
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 187 - 197
  • [6] HPV-POSITIVE PATIENTS WITH HEAD, NECK CANCER MAY HAVE BETTER OUTCOMES THAN HPV-NEGATIVE PATIENTS
    Snider, Janice
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2009, 140 (10): : 1222 - +
  • [7] Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer
    Jiron, Jose
    Sethi, Seema
    Ali-Fehmi, Rouba
    Franceschi, Silvia
    Struijk, Linda
    van Doorn, Leen-Jan
    Quint, Wim
    Kato, Ikuko
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2014, 35 (02) : 147 - 153
  • [8] Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
    Deneka, Alexander Y.
    Einarson, Margret B.
    Bennett, John
    Nikonova, Anna S.
    Elmekawy, Mohamed
    Zhou, Yan
    Lee, Jong Woo
    Burtness, Barbara A.
    Golemis, Erica A.
    CANCERS, 2020, 12 (02)
  • [9] BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer
    Liu, Xiyou
    Kumar, Manish
    Yang, Liangpeng
    Molkentine, David P.
    Valdecanas, David
    Yu, Shiying
    Meyn, Raymond E.
    Heymach, John V.
    Skinner, Heath D.
    CLINICAL CANCER RESEARCH, 2018, 24 (03) : 600 - 607
  • [10] Inducing and targeting senescence in HPV-negative head and neck squamous cancer cells
    Gadsden, Nicholas
    Thomas, Carlos
    Li, Daniel
    Shrivastava, Nitisha
    Schlecht, Nicolas
    Prystowsky, Michael
    Segall, Jeffrey
    Ow, Thomas
    CANCER RESEARCH, 2020, 80 (16)